| Year |
Citation |
Score |
| 2018 |
Rebecca VW, Nicastri MC, Fennelly C, Chude CI, Barber-Rotenberg JS, Ronghe A, McAfee Q, McLaughlin NP, Zhang G, Goldman AR, Ojha R, Piao S, Noguera-Ortega E, Martorella A, Alicea GM, et al. PPT1 promotes tumor growth and is the molecular target of chloroquine derivatives in cancer. Cancer Discovery. PMID 30442709 DOI: 10.1158/2159-8290.Cd-18-0706 |
0.581 |
|
| 2017 |
Rebecca VW, Nicastri MC, McLaughlin N, Fennelly C, McAfee Q, Ronghe A, Nofal M, Lim CY, Witze E, Chude CI, Zhang G, Alicea GM, Piao S, Murugan S, Ojha R, ... ... Barber-Rotenberg JS, et al. A unified approach to targeting the lysosome's degradative and growth signaling roles. Cancer Discovery. PMID 28899863 DOI: 10.1158/2159-8290.Cd-17-0741 |
0.597 |
|
| 2015 |
Qin J, Rajaratnam R, Feng L, Salami J, Barber-Rotenberg JS, Domsic J, Reyes-Uribe P, Liu H, Dang W, Berger SL, Villanueva J, Meggers E, Marmorstein R. Development of organometallic S6K1 inhibitors. Journal of Medicinal Chemistry. 58: 305-14. PMID 25356520 DOI: 10.1021/Jm5011868 |
0.56 |
|
| 2014 |
Hong SH, Youbi SE, Hong SP, Kallakury B, Monroe P, Erkizan HV, Barber-Rotenberg JS, Houghton P, Ãœren A, Toretsky JA. Pharmacokinetic modeling optimizes inhibition of the 'undruggable' EWS-FLI1 transcription factor in Ewing Sarcoma. Oncotarget. 5: 338-50. PMID 24481407 DOI: 10.18632/Oncotarget.1495 |
0.664 |
|
| 2012 |
Schlottmann S, Erkizan HV, Barber-Rotenberg JS, Knights C, Cheema A, Uren A, Avantaggiati ML, Toretsky JA. Acetylation Increases EWS-FLI1 DNA Binding and Transcriptional Activity. Frontiers in Oncology. 2: 107. PMID 22973553 DOI: 10.3389/Fonc.2012.00107 |
0.625 |
|
| 2012 |
Barber-Rotenberg JS, Selvanathan SP, Kong Y, Erkizan HV, Snyder TM, Hong SP, Kobs CL, South NL, Summer S, Monroe PJ, Chruszcz M, Dobrev V, Tosso PN, Scher LJ, Minor W, et al. Single enantiomer of YK-4-279 demonstrates specificity in targeting the oncogene EWS-FLI1. Oncotarget. 3: 172-82. PMID 22383402 DOI: 10.18632/Oncotarget.454 |
0.663 |
|
| 2011 |
Erkizan HV, Scher LJ, Gamble SE, Barber-Rotenberg JS, Sajwan KP, Üren A, Toretsky JA. Novel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors. Cell Cycle (Georgetown, Tex.). 10: 3397-408. PMID 21926473 DOI: 10.4161/Cc.10.19.17734 |
0.657 |
|
| 2011 |
Erkizan HV, Scher LM, Gamble E, Barber-Rotenberg J, Uren A, Toretsky J. Abstract 259: Novel peptide directed targeting of EWS-FLI1 impairs tumor cell growth Cancer Research. 71: 259-259. DOI: 10.1158/1538-7445.Am2011-259 |
0.585 |
|
| 2010 |
Schlottmann S, Erkizan HV, Barber-Rotenberg J, Uren A, Avantaggiati ML, Toretsky JA. Abstract 3897: EWS-FLI1 is regulated by acetylation Cancer Research. 70: 3897-3897. DOI: 10.1158/1538-7445.Am10-3897 |
0.649 |
|
| 2010 |
Toretsky JA, Erkizan HV, Kong Y, Merchant M, Barber-Rotenberg JS, Brown ML, Üren A. Abstract 3411: Targeting of EWS-FLI1 with small molecule YK-4-279 reduces xenograft growth by disruption of disordered protein-protein interactions Cancer Research. 70: 3411-3411. DOI: 10.1158/1538-7445.Am10-3411 |
0.671 |
|
| 2010 |
Barber-Rotenberg JS, Kong Y, Schnure N, Dakshanamurthy S, Frazier P, Erkizan HV, Brown ML, Uren A, Toretsky JA. Abstract 2681: EWS-FLI1 as a molecular target: Small molecule inhibitors for a disordered protein Cancer Research. 70: 2681-2681. DOI: 10.1158/1538-7445.Am10-2681 |
0.649 |
|
| 2009 |
Erkizan HV, Kong Y, Merchant M, Schlottmann S, Barber-Rotenberg JS, Yuan L, Abaan OD, Chou TH, Dakshanamurthy S, Brown ML, Uren A, Toretsky JA. A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma. Nature Medicine. 15: 750-6. PMID 19584866 DOI: 10.1038/Nm.1983 |
0.687 |
|
| Show low-probability matches. |